Literature DB >> 22551151

Pneumocystis jirovecii pneumonia 13 years post renal transplant following a recurrent cytomegalovirus infection.

A H Muhammad Iqbal1, S K Lim, K P Ng, L P Tan, Y B Chong, T C Keng.   

Abstract

Pneumocystis jirovecii (formerly Pneumocystis carinii) pneumonia (PCP) is a rare but serious infection that usually occurs within a year after solid organ transplantation. PCP may occur after 1 year post transplantation, but the rate is reported to be very low. Studies have shown an association between cytomegalovirus (CMV) infection in solid organ transplant patients and an increased risk of opportunistic infection. This increased risk is thought to be a result of the immunomodulatory effects of the CMV infection. We present a case of PCP infection occurring 13 years after a renal transplantation. This occurred following a recurrent CMV infection while the patient was on low-dose immunosuppressants.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551151     DOI: 10.1111/j.1399-3062.2012.00738.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  9 in total

1.  Early- and late-onset severe pneumonia after renal transplantation.

Authors:  Guowei Tu; Minjie Ju; Yijun Zheng; Ming Xu; Ruiming Rong; Duming Zhu; Tongyu Zhu; Zhe Luo
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Metagenomic Next-Generation Sequencing in Diagnosis of a Case of Pneumocystis jirovecii Pneumonia in a Kidney Transplant Recipient and Literature Review.

Authors:  Jie Chen; Ting He; Xiujun Li; Xue Wang; Li Peng; Liang Ma
Journal:  Infect Drug Resist       Date:  2020-08-13       Impact factor: 4.003

3.  Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients.

Authors:  Su Hwan Lee; Kyu Ha Huh; Dong Jin Joo; Myoung Soo Kim; Soon Il Kim; Juhan Lee; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Yu Seun Kim; Song Yee Kim
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

4.  Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome.

Authors:  Ji Eun Kim; Ahram Han; Hajeong Lee; Jongwon Ha; Yon Su Kim; Seung Seok Han
Journal:  BMC Nephrol       Date:  2019-06-10       Impact factor: 2.388

5.  Pneumocystis Jirovecii Pneumonia in a Kidney Transplant Recipient 13 Months after Transplantation: A Case Report and Literature Review.

Authors:  Dominykas Varnas; Augustina Jankauskienė
Journal:  Acta Med Litu       Date:  2021-01-25

6.  Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients.

Authors:  Jianlei Ji; Qinghai Wang; Tao Huang; Ziyu Wang; Pingli He; Chen Guo; Weijia Xu; Yanwei Cao; Zhen Dong; Hongyang Wang
Journal:  Infect Drug Resist       Date:  2021-11-24       Impact factor: 4.003

7.  Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.

Authors:  Jing Peng; Ming Ni; Dunfeng Du; Yanjun Lu; Juan Song; Weiyong Liu; Na Shen; Xiong Wang; Yaowu Zhu; Bruce A Vallance; Ziyong Sun; Hong Bing Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-12-15       Impact factor: 3.944

8.  Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study.

Authors:  Viviana Navarro-Rodríguez; Alvaro Herrera-Munoz; Adrián Castro; Allan Ramos-Esquivel
Journal:  J Nephropathol       Date:  2017-04-02

9.  Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report.

Authors:  Prithiv Prasad; Kevin Bryan Lo; Pradhum Ram
Journal:  Med Mycol Case Rep       Date:  2018-02-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.